Accessibility Statement Skip Navigation
  • Resources
  • Investor Relations
  • Journalists
  • Webcasts
  • Français
  • my CNW 
    • Login
    • Register
  • Client Login 
    • PR Newswire Amplify™
    • Next Gen Communications Cloud
    • Cision Communications Cloud®
  • Sign Up
  • Send a Release
Return to PR Newswire homepage
  • News
  • Products
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
Advanced Search
  • News in Focus
      • Browse News Releases

      • All News Releases
      • All Public Company
      • News Releases Overview

      • Multimedia Gallery

      • All Multimedia
      • All Photos
      • All Videos
      • Multimedia Gallery Overview

      • Trending Topics

      • All Trending Topics
  • Business
      • Auto & Transportation

      • All Automotive & Transportation
      • Aerospace, Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads and Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking and Road Transportation
      • Auto & Transportation Overview

      • View All Auto & Transportation

      • Business Technology

      • All Business Technology
      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • Business Technology Overview

      • View All Business Technology

      • Entertain­ment & Media

      • All Entertain­ment & Media
      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • Entertain­ment & Media Overview

      • View All Entertain­ment & Media

      • Financial Services & Investing

      • All Financial Services & Investing
      • Accounting News & Issues
      • Acquisitions, Mergers and Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalization
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • Financial Services & Investing Overview

      • View All Financial Services & Investing

      • General Business

      • All General Business
      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls and Research
      • Trade Show News
      • General Business Overview

      • View All General Business

  • Science & Tech
      • Consumer Technology

      • All Consumer Technology
      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • Consumer Technology Overview

      • View All Consumer Technology

      • Energy & Natural Resources

      • All Energy
      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil and Gas Discoveries
      • Utilities
      • Water Utilities
      • Energy & Natural Resources Overview

      • View All Energy & Natural Resources

      • Environ­ment

      • All Environ­ment
      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • Environ­ment Overview

      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • All Heavy Industry & Manufacturing
      • Aerospace & Defense
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation and Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking and Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • Heavy Industry & Manufacturing Overview

      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • All Telecomm­unications
      • Carriers and Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • Telecomm­unications Overview

      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • All Consumer Products & Retail
      • Animals & Pets
      • Beers, Wines and Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics and Personal Care
      • Fashion
      • Food & Beverages
      • Furniture and Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewelry
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • Consumer Products & Retail Overview

      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • All Entertain­ment & Media
      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • Entertain­ment & Media Overview

      • View All Entertain­ment & Media

      • Health

      • All Health
      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • Health Overview

      • View All Health

      • Sports

      • All Sports
      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • Sports Overview

      • View All Sports

      • Travel

      • All Travel
      • Amusement Parks and Tourist Attractions
      • Gambling & Casinos
      • Hotels and Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • Travel Overview

      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • All Policy & Public Interest
      • Advocacy Group Opinion
      • Animal Welfare
      • Canadian Federal Government
      • Canadian Municipal Government
      • Canadian Provincial Government
      • Corporate Social Responsibility
      • Domestic Policy
      • Economic News, Trends, Analysis
      • Education
      • Environmental
      • European Government
      • FDA Approval
      • Federal and State Legislation
      • Federal Executive Branch & Agency
      • Foreign Policy & International Affairs
      • Homeland Security
      • Labor & Union
      • Legal Issues
      • Natural Disasters
      • Not For Profit
      • Patent Law
      • Public Safety
      • Trade Policy
      • Policy & Public Interest Overview

      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • All People & Culture
      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • People & Culture Overview

      • View All People & Culture

  • Advanced Search
  • Explore Our Platform
  • Plan Campaigns
  • Create with AI
  • Distribute Press Releases
  • Report Results
  • Amplify Content
  • IR
  • All Products
  • Become a Client
  • Request a Demo
  • Editorial Bureaus
  • Partnerships
  • General Enquiries
  • Media
  • Worldwide Offices
  • Hamburger menu
  • Cision Canada
  • Send a Release
  • FR
    • Phone

    • 877-269-7890 from 8 AM - 10 PM ET

    • ALL CONTACT INFO
    • Contact Cision

      877-269-7890
      from 8 AM - 10 PM ET

  • Send a Release
  • Sign Up
  • Resources
  • Investor Relations
  • Journalists
  • Webcasts
  • my CNW
  • GDPR
  • News in Focus
    • Browse All News
    • Multimedia Gallery
    • Trending Topics
  • Business
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
    • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Send a Release
  • Sign Up
  • Resources
  • Investor Relations
  • Journalists
  • Webcasts
  • my CNW
  • GDPR
  • Explore Our Platform
  • Plan Campaigns
  • Create with AI
  • Distribute Press Releases
  • Report Results
  • Amplify Content
  • IR
  • All Products
  • Send a Release
  • Sign Up
  • Resources
  • Investor Relations
  • Journalists
  • Webcasts
  • my CNW
  • GDPR
  • Sign Up
  • Request a Demo
  • Editorial Bureaus
  • Partnerships
  • General Enquiries
  • Media Enquiries
  • Worldwide Offices
  • Send a Release
  • Sign Up
  • Resources
  • Investor Relations
  • Journalists
  • Webcasts
  • my CNW
  • GDPR

"A Million Discoveries: How the Amgen Biotech Experience Shapes Future Innovators"

Amgen logo (CNW Group/Amgen Canada)

News provided by

Amgen Canada

Sep 09, 2024, 08:30 ET

Share this article

Share toX

Share this article

Share toX

MISSISSAUGA, ON, Sept. 9, 2024 /CNW/ - The Amgen Biotech Experience (ABE) is celebrating a milestone that speaks volumes—not just a number, but a clear message of growth and enthusiasm in the science community. Welcoming its one-millionth student, ABE isn't just counting participants in Canada and 15 other countries; it's celebrating a movement towards a more inclusive and engaging science education across the globe.

Continue Reading
Left to right: Eva Bruni (DPCDSB Academic Consultant, science 7-12), Kristina Han (ABE@UTM Site Coordinator) and Jennifer Moreira (Science teacher, St. Michaels Catholic Secondary School) discussing results at the July 2024 teacher training session. (CNW Group/Amgen Canada)
Left to right: Eva Bruni (DPCDSB Academic Consultant, science 7-12), Kristina Han (ABE@UTM Site Coordinator) and Jennifer Moreira (Science teacher, St. Michaels Catholic Secondary School) discussing results at the July 2024 teacher training session. (CNW Group/Amgen Canada)

In 2016, the Amgen Biotech Experience came to Canada in partnership with the University of Toronto Mississauga. In 2023, the program expanded with a second site at Carleton University. Since its expansion, the Amgen Biotech Experience has reached over 8,000 Canadian students and engaged over 100 Canadian teachers.

"Amgen Canada salutes all one million ABE participants around the world and is inspired by the commitment of the program's 4,400 teachers over the last thirty-four years," says Ugur Gunaydin, vice-president and general manager, Amgen Canada. "We are proud to be a part of this global community. In Canada, ABE is further enriched by our staff volunteers who share their personal career stories with classrooms and teachers."

Transforming Classrooms into Hubs of Discover

By turning schools into vibrant labs, ABE has democratized biotechnology by bringing the real work of science out of professional labs and into classrooms. It's giving students from various backgrounds the tools and confidence to dive into biotech, often for the first time. These hands-on experiences have opened eyes and minds to the possibilities that science holds from curing diseases to solving environmental challenges.

"Reaching the one million student mark with the Amgen Biotech Experience is a milestone we're really proud of," says Scott Heimlich, president, Amgen Foundation. "It's about partnering with teachers to show a million young minds that science is exciting and within their reach. We've always believed in the power of hands-on learning to spark curiosity and passion for science. I'm grateful to be a part of this journey and excited about the future possibilities ABE opens up for students."

This achievement isn't just about teaching kids how to use micropipettes or understand DNA. It's about showing them that science is for everyone and that their ideas and experiments can contribute to our world in meaningful ways.

"The Amgen Biotech Experience at University of Toronto Mississauga is such a unique program that nurtures interest in life sciences and the development of science investigation skills, feeding a critical talent pipeline," says Alexandra Gillespie, vice-president, University of Toronto and principal, U of T Mississauga. "The program allows high school students the opportunity to explore biotechnology in a supportive environment, giving them a window into future pathways in life sciences, including research and discovery."

Real Stories, Real Impact

Originating with Amgen scientists outreaching to local high school science teachers in the company's headquarters community in Thousand Oaks California, the ABE program has grown since 1990 to become a global program available at 27 selected locations in 16 countries.

In Canada, the program has expanded to two program sites. These sites are located at the University of Toronto Mississauga and Carleton University. Its growth reflects a shift in how science is taught and learned, moving towards an approach that's more inclusive, interactive, and impactful through its incorporation of research-grade equipment and a curriculum based on real-world science.

Take Yusra from Stephen Lewis Secondary School in Mississauga:

"Amgen has been a transformational experience that has illuminated a whole new world of genetics for me. We often learn theory and forget the true purpose of learning. Amgen made it real. It made the concept of experimentation, engineering, and becoming a scientist extremely attainable instead of a far-fetched idea. Genetics has always been fascinating to me, and the fact that I was able to use my knowledge from class and apply it during the genetic engineering process excited me beyond measure. It was extremely rewarding to see the fruit of my hard work in the form of a glowing red petri dish. To some, this may seem insignificant, but the red glow represents more than just genetically modified bacteria for me. It represents a future that I have the ability to change and improve by making changes on the microscopic scale for a macroscopic effect, and it's all thanks to Amgen for this truly wonderful experience."

Or this student quote provided anonymously in response to the question 'what will you remember in 3 years?' "…even though we didn't succeed, we got to do something that used to be done only in uni labs in the past. So, I would remember it as a very privileged experience if that makes sense. And if I end up pursuing biotechnology, I will look back and think 'wow that was the moment I decided I wanted to be a biotechnologist".

And take Jennifer, a teacher at a school in the heart of downtown Toronto who is "confident that students will remember the biotech material better than just about anything else in the Grade 12 course."

What Comes Next

Crossing the one-million mark is an incredible milestone, but for ABE and the Amgen Foundation, it's just the beginning. The Foundation has committed an additional $7 million dollars to continue the work of the ABE program, bringing its overall commitment to more than $60 million to date. The mission ahead is to continuously improve the program's impact, reaching more students, and igniting more sparks of scientific curiosity. The ABE labs are also available online on https://abe.labxchange.org/ in many languages, complementing the in-person experience and allowing this content to reach far beyond its current communities.

Join the Movement

As we celebrate this significant moment, we invite you to learn more about the Amgen Biotech Experience and the other free science education programs provided by the Amgen Foundation at www.amgenfoundation.org, because everyone needs science and science needs everyone.

About Amgen 

As a leader in innovation, Amgen in Canada understands the value of science. With main operations located in Mississauga, Ontario's vibrant biomedical cluster, and its research facility in Burnaby, B.C., Amgen Canada has been an important contributor to advancements in science and innovation in Canada since 1991. The company contributes to the development of new therapies and new ways of using existing medicines in partnership with many of Canada's leading healthcare, academic, research, government, and patient organizations. To learn more, visit www.amgen.ca 

SOURCE Amgen Canada

Natasha Bond, Sr. Manager Corporate Affairs, Amgen Canada Inc., Phone: (905)-285-3007, Email: [email protected]

Modal title

Organization Profile

Amgen Canada

    Also from this source

  • ONTARIO AND QUEBEC EXPAND PUBLIC COVERAGE OF REPATHA® FOR ELIGIBLE RECENT ACUTE CORONARY SYNDROME PATIENTS

Contact Cision

  • 866-245-2317
    from 8 AM - 10 PM ET
  • Become a Client
  • Request a Demo
  • Editorial Bureaus
  • Partnerships
  • General Enquiries
  • Media

Products

  • Cision Communications Cloud®
  • Media Monitoring
  • Content Distribution
  • Multimedia Distribution
  • Measurement & Analytics
  • Investor Relations

About

  • About Cision Canada
  • About Cision
  • Media Partners
  • Careers
  • Accessibility Statement
  • APAC
  • APAC - Simplified Chinese
  • APAC - Traditional Chinese
  • Brazil
  • Canada
  • Czech
  • Denmark
  • Finland
  • France
  • Germany
  • India
  • Indonesia
  • Israel
  • Japan
  • Korea
  • Mexico
  • Middle East
  • Middle East - Arabic
  • Netherlands
  • Norway
  • Poland
  • Portugal
  • Russia
  • Slovakia
  • Spain
  • Sweden
  • United States
  • Vietnam

My Services

  • All News Releases
  • Platform Login
  • Next Gen Communications Cloud
  • Cision Communications Cloud®
  • my CNW
  • Data Privacy

Do not sell or share my personal information:

  • Submit via [email protected] 
  • Call Privacy toll-free: 877-297-8921

Contact Cision

Products

About

My Services
  • All News Releases
  • Platform
  • Next Gen Communications Cloud
  • Cision Communications Cloud
  • my CNW
877-269-7890
from 8 AM - 10 PM ET
  • Terms of Use
  • Information Security Policy
  • Site Map
  • Cookie Settings
  • Accessibility Statement
Copyright © 2025 CNW Group Ltd. All Rights Reserved. A Cision company.